Hospital Pharmacy Compounding against COVID-19 pandemic

• Príomhchruthaitheoirí: José María Alonso-Herreros (Údar), Silvia Berisa-Prado (Údar), Carme Cañete-Ramírez (Údar), María del Pilar Flox-Benítez (Údar), Margarita Ladrón de Guevara-García (Údar), Carmen López-Cabezas (Údar), Ana María Martín de Rosales-Cabrera (Údar), Beatriz Ramos-Martínez (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Elsevier, 2020-06-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

As in other areas of the health system, COVID-19 has had a dramatic impact on hospital compounding. This area has faced numerous challenges, including the shortage of frequent-use products (hydroalcoholic solutions, lopinavir/ritonavir suspension), the use of new preparations for SARS-CoV-2 (tociliz...